ImmunoPrecise Antibodies Ltd. Form 6-K Filing Insights - December 2024
The key information extracted from the provided section of the financial report, which is a Form 6-K filed by ImmunoPrecise Antibodies Ltd., is as follows:
- Company Name: ImmunoPrecise Antibodies Ltd.
- Filing Type: Form 6-K (Report of Foreign Private Issuer)
- Filing Date: December 23, 2024
- Commission File Number: 001-39530
- Address of Principal Executive Office:
- 3204 - 4464 Markham Street
- Victoria, British Columbia, V8Z 7X8, Canada
- Report Purpose: The filing is made under the Securities Exchange Act of 1934, indicating compliance with reporting requirements for foreign private issuers.
- Indication of Annual Reports: The report checks 'Form 20-F' indicating that the registrant will file annual reports under this form, while 'Form 40-F' is not checked.
- Signatory Information:
- Name: Kristin Taylor
- Title: Chief Financial Officer
- Signature: Signed as /s/ Kristin Taylor
These points summarize the essential details and compliance aspects of the filing, which are relevant for stakeholders analyzing the company's regulatory submissions and corporate governance.
